Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain von Escobar Cervantes, Carlos, Martí-Almor, Julio, Cabeza, Alejandro Isidoro Pérez, Bowrin, Kevin, Llorac Moix, Aleix, Genís Gironès, Mar, Gasche, David, Millier, Aurélie, Tardu, Jean, Toumi, Mondher, Briere, Jean-Baptiste

Volltext

Budget Impact of Rivaroxaban for the Prevention of Thromboembolic Events after Hip or Knee Replacement in Spain von Granero Xiberta, Xavier, Murcia, Antonio, Troncoso Durán, José Ricardo, Gómez Zubeldia, Claudio, Llorac Moix, Aleix, Graefenhain De Codes, Ruth, Ferrario, Maria Giovana, Lizán, Luis

Volltext

Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain von Escobar Cervantes, Carlos, Martí Almor, Julio, Pérez Cabeza, Alejandro Isidoro, Bowrin, Kevin, Llorac Moix, Aleix, Genís Gironès, Mar, Gasche, David, Aurélie, Millier, Tardu, Jean, Toumi, Mondher, Briere, Jean-Baptiste

Volltext

Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain von Carlos Escobar Cervantes, Julio Martí-Almor, Alejandro Isidoro Pérez Cabeza, Kevin Bowrin, Aleix Llorac Moix, Mar Genís Gironès, David Gasche, Aurélie Millier, Jean Tardu, Mondher Toumi, Jean-Baptiste Briere

Volltext